FDA DrugClass IINotable

FDA Recall: norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services

Date: 2026-04-15
Brand: Fagron Compounding Services
Category: Drug
FDA Class: Class II

Description

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Hazard

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Remedy

25,260 bags

View original recall →
Share:

Related Recalls

2026-04-15 · FDA_DRUG
FDA Recall: norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Service
Fagron Compounding Services
2026-04-15 · FDA_DRUG
FDA Recall: Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Servi
Fagron Compounding Services
2026-04-15 · FDA_DRUG
FDA Recall: Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Servic
Fagron Compounding Services
2026-04-15 · FDA_DRUG
FDA Recall: Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services,
Fagron Compounding Services